REED ELIZABETH E sold TVTX
April 1, 2026 · Form 4 insider transaction
REED ELIZABETH E sold 10,000 shares of Travere Therapeutics, Inc. at $30.00 per share, a transaction worth $300.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$30.00
Total value
$300.0K
InsiderREED ELIZABETH E
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after105,211
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option grant to the Reporting Person on January 31, 2020.